Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)434-436
Number of pages3
JournalThe Lancet Oncology
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

ASJC Scopus subject areas

  • Oncology

Cite this

Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer : a new standard of care? / Curigliano, Giuseppe.

In: The Lancet Oncology, Vol. 19, No. 4, 01.04.2018, p. 434-436.

Research output: Contribution to journalComment/debate

@article{f0466d682f48431396b00550ee69e9b8,
title = "Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?",
author = "Giuseppe Curigliano",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/S1470-2045(18)30129-3",
language = "English",
volume = "19",
pages = "434--436",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",

}

TY - JOUR

T1 - Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer

T2 - a new standard of care?

AU - Curigliano, Giuseppe

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85042588931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042588931&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30129-3

DO - 10.1016/S1470-2045(18)30129-3

M3 - Comment/debate

AN - SCOPUS:85042588931

VL - 19

SP - 434

EP - 436

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -